PFE and JNJ Annual Dividend Income of $3,540 for Investors
Published on Β· Source: finance.yahoo.com
AI Summary
Summarized by AI from the source belowInvestors holding 500 shares each of Pfizer (PFE) and Johnson & Johnson (JNJ) can expect an annual passive income of $3,540 on a $127,000 investment, with a blended yield of 2.79%. JNJ recently increased its quarterly dividend to $1.34, marking its 64th consecutive increase, supported by a AAA-rated balance sheet and $19.7 billion in free cash flow. Meanwhile, PFE's yield stands at 6.8%, reflecting stock compression. JNJ reported Q1 2026 revenues of $15.426 billion in pharmaceuticals, an 11.2% year-over-year increase, while MedTech revenue reached $8.636 billion, up 7.7%.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
About Johnson & Johnson (JNJ)
Johnson & Johnson is a healthcare giant spanning pharmaceuticals and medical devices, known for its deep drug pipeline.
The Health Care sector covers pharmaceutical, biotech, device and managed-care companies.
Earlier JNJ news
- Johnson & Johnson (JNJ) Shares Up 53% in Past Year
- J&J (JNJ) Expands US Rollout of TECNIS Cataract Lens
- Dividend Strategy Beats 4% Rule by Up to $430K Over 20 Years
- Dividend Portfolio Return: $43,770 Annual Income and $7,515 Tax Impact
- IHE vs IXJ: 39.7% vs 10% 1-Year Returns in ETFs Comparison
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
Related News
Aeromexico Plans New US Flights After Washington Lifts Restrictions
Oct 19
SpaceX AI Computing Power Rental Driving Revenue Growth but Raising Costs
Oct 19
S&P 500 and Nasdaq Rise as AI Stocks Rebound Before Earnings
Oct 19
A&W (TSX:AW) Q3 Results Show Margin Squeeze Impact
Oct 18